Overview

A Prospective Cohort of Children With HIV Infection

Status:
Recruiting
Trial end date:
2030-12-01
Target enrollment:
Participant gender:
Summary
To evaluate clinical and immunological outcome of children treated with HAART.
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborator:
Khon Kaen University
Treatments:
Didanosine
Efavirenz
Indinavir
Lamivudine
Nelfinavir
Nevirapine
Ritonavir
Saquinavir
Stavudine
Zidovudine